环丙沙星对膜生物反应器中微生物群落及抗性基因的影响

用膜生物反应器(membrane bioreactor,MBR)处理含环丙沙星(ciprofloxacin,CIP)的合成废水,考察了不同CIP进水浓度(0、5、10、15 mg·L-1)下MBR的微生物群落特征和抗性基因丰度的变化.结果表明,随着进水中CIP浓度从0 mg·L-1增加至15 mg·L-1,变形菌门(Proteobacteria)和拟杆菌门(Bacteroidetes)仍保持为优势菌门,相对丰度比例分别为57.5%和12.7%;红环菌科(Rhodocyclaceae)、Chitinophagaceae和丛毛单胞菌科(Comamonadaceae)被选择成为优势菌科,比例分别为29.96%、5.44%和6.60%;Methyloversatilis、Ferruginibacter、动胶菌属(Zoogloea)和丛毛单胞菌属(Comamonas)被选择成为优势菌属,比例分别为21.70%、7.56%、5.24%和4.15%;Chao1、ACE、Shannon指数逐渐降低和Simpson指数逐渐升高,表明MBR污泥中微生物丰富度和多样性均降低;亚硝化单胞菌属(Nitrosomonas)、硝化螺旋菌属(Nitrospira)、产碱菌属(Alcaligenes)和硝化杆菌属(Nitrobacter)相对丰度减少,使得氨氮去除率降低.CIP抗性基因(CIP-ARGs)分析表明,当MBR在CIP投加浓度为5 mg·L-1下运行至第33 d时,反应器中的gyr A、gyr B和par C基因相对丰度较CIP投加初期增加,加大了抗药风险.

Influence of Ciprofloxacin on the Microbial Community and Antibiotics Resistance Genes in a Membrane Bioreactor

A membrane bioreactor (MBR) was used to treat ciprofloxacin (CIP)-contaminated artificial wastewater. The microbial community structure and the abundance of antibiotic resistant genes (ARGs) in the MBR were studied at four CIP dosages (0, 5 mg·L^-1, 10 mg·L^-1, and 15 mg·L^-1). The results showed that Proteobacteria and Bacteroidetes remained the dominant phylum, with relative abundances of 57.5% and 12.7%, respectively, as the dosage of CIP was increased from 0 mg·L^-1 to 15 mg·L^-1. Rhodocyclaceae, Chitinophagaceae, and Comamonadaceae became the dominant family with abundances of 29.96%, 5.44%, and 6.60%, respectively. Methyloversatilis, Ferruginibacter, Zoogloea, and Comamonas became the dominant genus, with relative abundances of 21.70%, 7.56%, 5.24%, and 4.15%, respectively. The decrease of Chao1, ACE, and Shannon and the increase of Simpson indicated a decrease in microbial abundance and diversity. The relative abundances of Nitrosomonas, Nitrospira, Alcaligenes, and Nitrobacter decreased, which caused a decrease in the NH₃-N removal rate. A CIP-ARGs analysis revealed that the relative abundances of gyrA, gyrB, and parC were increased, beginning after the sludge was dosed with 5 mg·L^-1of CIP for 33 days, which augmented the risk for microbial drug-resistance.